Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electrons | 1 | 2023 | 269 | 0.840 |
Why?
|
Radiotherapy, Conformal | 1 | 2023 | 548 | 0.720 |
Why?
|
Saudi Arabia | 4 | 2023 | 209 | 0.360 |
Why?
|
Phlebitis | 1 | 2023 | 30 | 0.230 |
Why?
|
Receptor, erbB-2 | 3 | 2021 | 2370 | 0.210 |
Why?
|
Neoadjuvant Therapy | 3 | 2021 | 2688 | 0.190 |
Why?
|
Candidiasis, Vulvovaginal | 1 | 2019 | 24 | 0.180 |
Why?
|
Receptors, Progesterone | 2 | 2021 | 1094 | 0.170 |
Why?
|
Yeasts | 1 | 2019 | 285 | 0.160 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2023 | 1771 | 0.160 |
Why?
|
Receptors, Estrogen | 2 | 2021 | 2183 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2023 | 11699 | 0.130 |
Why?
|
Antifungal Agents | 1 | 2019 | 722 | 0.120 |
Why?
|
Vagina | 1 | 2019 | 822 | 0.120 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2019 | 778 | 0.110 |
Why?
|
Adrenal Cortex Hormones | 1 | 2019 | 1833 | 0.090 |
Why?
|
Carcinoma | 1 | 2020 | 2361 | 0.080 |
Why?
|
Obesity | 2 | 2023 | 12643 | 0.080 |
Why?
|
Breast Neoplasms | 3 | 2021 | 20676 | 0.080 |
Why?
|
Weight Loss | 3 | 2023 | 2589 | 0.080 |
Why?
|
Life Style | 3 | 2023 | 3817 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2019 | 2196 | 0.070 |
Why?
|
Saline Solution, Hypertonic | 1 | 2023 | 110 | 0.050 |
Why?
|
Erythema | 1 | 2023 | 254 | 0.050 |
Why?
|
Body Mass Index | 1 | 2019 | 12655 | 0.050 |
Why?
|
Disease-Free Survival | 2 | 2021 | 6871 | 0.050 |
Why?
|
Keratin-5 | 1 | 2019 | 47 | 0.040 |
Why?
|
Cyclin B1 | 1 | 2019 | 51 | 0.040 |
Why?
|
Prognosis | 4 | 2021 | 28901 | 0.040 |
Why?
|
Edema | 1 | 2023 | 791 | 0.040 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2019 | 105 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11410 | 0.040 |
Why?
|
Infusions, Intravenous | 1 | 2023 | 2270 | 0.040 |
Why?
|
Middle Aged | 5 | 2023 | 212863 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13635 | 0.040 |
Why?
|
Survival Rate | 2 | 2020 | 12761 | 0.030 |
Why?
|
Carcinoma, Lobular | 1 | 2019 | 482 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2021 | 2634 | 0.030 |
Why?
|
Humans | 10 | 2023 | 739398 | 0.030 |
Why?
|
Female | 6 | 2023 | 378853 | 0.030 |
Why?
|
Young Adult | 4 | 2021 | 56255 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3453 | 0.030 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2019 | 1100 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2948 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8307 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 13880 | 0.020 |
Why?
|
Survival Analysis | 1 | 2019 | 10247 | 0.020 |
Why?
|
Adult | 4 | 2021 | 213394 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2019 | 11347 | 0.020 |
Why?
|
Age Factors | 1 | 2019 | 18349 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2020 | 76631 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 20913 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 24714 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40050 | 0.010 |
Why?
|
Aged | 2 | 2020 | 162698 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 38942 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 53037 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2019 | 57650 | 0.010 |
Why?
|
Male | 1 | 2019 | 349022 | 0.000 |
Why?
|
Concepts
(59)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_